Genomics-based labeling and attribution: a case for integrating social sciences into personalized medicine research

By Haga Susanne B  

Personalized Medicine, Vol. 3, Iss. 3, 2006-08 ,pp. : 317-323

Future Medicine

Access to resources Recommend Favorite

Managing the Innovation Supply Chain to Maximize Personalized Medicine

By  

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 95, Iss. 2, 2014-02 ,pp. : 113-118

John Wiley & Sons Inc

Access to resources Recommend Favorite

Initial development of an evidence base for personalized medicine’s translation to clinical practice and health policy

By Phillips Kathryn A   Van Bebber Stephanie L   Issa Amalia M  

Personalized Medicine, Vol. 3, Iss. 4, 2006-11 ,pp. : 411-414

Future Medicine

Access to resources Recommend Favorite

Coriell Personalized Medicine Collaborative^®: a prospective study of the utility of personalized medicine

By Keller Margaret A   Gordon Erynn S   Stack Catharine B   Gharani Neda   Sill Courtney J   Schmidlen Tara J   Joseph Mintzer   Pallies John   Gerry Norman P   Christman Michael F  

Personalized Medicine, Vol. 7, Iss. 3, 2010-05 ,pp. : 301-317

Future Medicine

Access to resources Recommend Favorite

When Clinical Trial Participation Is Not an Option in the Era of Personalized Medicine: The Case of Two Patients

By  

Oncology, Vol. 92, Iss. 1, 2016-11 ,pp. : 55-60

Karger

Access to resources Recommend Favorite